Quantitative determination of 8-isoprostaglandin F2α in human urine using microfluidic chip-based nano-liquid chromatography with on-chip sample enrichment and tandem mass spectrometry

Increased F ₂ ‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation <i>in vivo</i>

Domenico Praticò, Virginia M.‐Y. Lee, John Q. Trojanowski et al. · The FASEB Journal · 1998 · 403 citations

Life Sciences, Neurobiology, Neuroscience +17

Microfluidic Chip for Peptide Analysis with an Integrated HPLC Column, Sample Enrichment Column, and Nanoelectrospray Tip

Hongfeng Yin, Kevin Killeen, Reid A. Brennen et al. · Analytical Chemistry · 2004 · 353 citations

Engineering, Bioengineering, Mass Spectrometric Analysis +16

Urinary 8-iso-Prostaglandin F _2α as a Risk Marker in Patients With Coronary Heart Disease

Edzard Schwedhelm, Asja Bartling, Henrike Lenzen et al. · Circulation · 2004 · 268 citations · Full text

Veterinary Medicine, Cardiology, Metabolomics +16

Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry

Julie M. Proudfoot, Anne Barden, Trevor A. Mori et al. · Analytical Biochemistry · 1999 · 175 citations

Life Sciences, Biochemistry, Analytical Toxicology +10

Quantification of the Major Urinary Metabolite of 15-F2t-Isoprostane (8-iso-PGF2α) by a Stable Isotope Dilution Mass Spectrometric Assay

Jason D. Morrow, William E. Zackert, James P. Yang et al. · Analytical Biochemistry · 1999 · 153 citations

Life Sciences, Biochemistry, Pharmacology +12